Rachel Mears is a partner at Jeito Capital and has over 20 years of transactional, operational, and legal experience in biotechnology and pharma companies. She led Strategy and International Business Operations at Forest Laboratories, where she worked on the successful development and commercialization of more than 10 FDA approved drugs, including Lexapro®, Namenda®, Linzess®, Vraylar® and AvyCaz®, and spearheaded the company’s integration with Allergan (then known as Actavis). She also served as Chief Business Officer and General Counsel at Modern Meadow, a biotechnology company focused on sustainable materials and as Senior Counsel, Chief of Staff to PepsiCo’s General Counsel.
Rachel began her career as a patent attorney, first with Morrison & Forester and later Kirkland & Ellis, specializing in complex intellectual property strategy and litigation. She serves on the Board of Trustees at Hackley School. Rachel received her B.S. degree with honors in chemistry from Stanford University and her J.D. degree from NYU School of Law and is admitted to the US Patent Bar.